Stock Plans And Stock-Based Compensation (Narrative) (Details) (USD $)	12 Months Ended					12 Months Ended										36 Months Ended	12 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2012 SSARs/Stock Options [Member]	Jun. 30, 2013 SSARs/Stock Options [Member]	Jun. 30, 2013 Restricted Shares And Restricted Stock Units [Member]	Jun. 30, 2012 Restricted Shares And Restricted Stock Units [Member]	Jun. 30, 2011 Restricted Shares And Restricted Stock Units [Member]	Jun. 30, 2013 2006 Plan [Member]	Jun. 30, 2011 Restricted Shares And Non-Performance Based Restricted Stock Units [Member]	Jun. 30, 2013 Stock Appreciation Rights (SARs) [Member]	Jun. 30, 2013 PRSUs [Member]	Jun. 30, 2012 PRSUs [Member]	Jun. 30, 2013 ESPP [Member]	Jun. 30, 2013 MSPP [Member]	Jun. 30, 2013 MSPP [Member]	Jun. 30, 2013 DSPP [Member]	Jun. 30, 2013 Chief Executive Officer [Member] item	Jun. 30, 2013 Participants [Member] ESPP [Member]	Jun. 30, 2013 Employees [Member] ESPP [Member]	Jun. 30, 2012 Director [Member] DSPP [Member]	Jun. 30, 2013 Senior Executive [Member] MSPP [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Excess tax benefits recognized	$ 1,600,000	$ 400,000	$ 2,200,000
Vesting period (in years)										3 years	5 years				3 years
Vesting period one	3 years
Vesting period two	4 years
Vesting period three	5 years
Number of shares authorized for grants									12,450,000					1,000,000	500,000	500,000	75,000
Cumulative grants of equity instruments									12,911,686
Number of equity instruments forfeited	10,350	32,630	85,460						4,005,519
Maximum exercisable period for non-qualified stock options	10 years
Term of equity instruments granted (in years)	7 years
Vesting percentage based on death or permanent disability of grantees	100.00%
Vesting percentage based upon retirement	100.00%
PRSUs granted						605,277	817,918	800,112				238,810			10,160		1,148	300,000
Stock price performance measurement period												90 days	90 days
Number of vesting periods																		3
Weighted-average fair value of equity instruments granted						$ 59.07	$ 47.34	$ 43.79
Total intrinsic value of RSUs that vested	17,600,000	13,400,000	15,400,000
Tax benefit realized from vesting of restricted stock units	3,342,000	6,062,000	6,549,000			6,900,000	5,300,000	6,100,000
Grant date fair value of stock options vested	5,000,000	11,400,000	13,700,000
Unrecognized compensation cost					60,000	24,300,000
Weighted-average period to recognize unrecognized compensation cost (in years)						2 years 2 months 12 days
Share purchase price over fair market value														95.00%		85.00%
Maximum number of shares that an eligible employee can purchase	The maximum number of shares that an eligible employee can purchase during any quarter is equal to two times an amount determined as follows: 20 percent of such employee's compensation over the quarter, divided by 95 percent of the fair market value of a share of common stock on the last day of the quarter
Percent of employee compensation over the quarter	20.00%
Percent of fair market value of shares	95.00%
Stock-based compensation expense	$ 8,832,000	$ 15,499,000	$ 17,915,000
Percentage of annual bonus in lieu of which RSU received																						100.00%
Shares purchased under ESPP																			938,233	78,225
Percentage of annual retainer fees in lieu of which RSU received																					100.00%
Weighted-average purchase price per share																			$ 46.41	$ 52.09